12:00 AM
 | 
May 11, 2009
 |  BioCentury  |  Finance

EPS Watch

EPS Watch

Company 1Q09 EPS est 1Q09 EPS actual Outcome Growth from 1Q08 5/8 cls Wk chg % chg Mcap chg 5/8 Mcap
Cephalon Inc. $1.27 $1.30 Beat by $0.03 27% $65.63 $1.44 2% $99.1 $4,514.8
(NASDAQ:CEPH) 1Q09 sales rose 17% to $520M from $443.2M in 1Q08. Sales from the company's cancer portfolio increased 179% to $76.6M from $27.5M due to the launch of Treanda bendamustine last April. The alkylating agent...

Read the full 553 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >